US Stock MarketDetailed Quotes

CGEN Compugen

Watchlist
  • 1.9000
  • +0.0200+1.06%
Close Apr 19 16:00 ET
170.11MMarket Cap-9047P/E (TTM)

About Compugen Company

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Company Profile

SymbolCGEN
Company NameCompugen
Listing DateAug 11, 2000
Issue Price10.00
Founded1993
CEODr. Anat Cohen-Dayag, PhD
MarketNASDAQ
Employees68
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressAzrieli Center,26 Harokmim Street,Building D
CityHolon
ProvinceTel Aviv
CountryIsrael
Zip Code58858
Phone972-3-765-8585
Websitehttp://www.cgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Anat Cohen-Dayag, PhD
  • Director, President and Chief Executive Officer
  • 1.46M
  • Alberto Sessa
  • Chief Financial Officer
  • --
  • Dr. Eran Ophir
  • Chief Scientific Officer
  • 540.64K
  • Dr. Yaron Turpaz, PhD
  • Senior Vice President and Senior Advisor, Computational Discovery
  • --
  • Dr. Pierre Ferre, Pd.D
  • Vice President, Preclinical Development
  • 570.40K
  • Dr. Zurit Levine,PhD
  • Senior Vice President, Technology Innovation
  • 532.26K
  • Paul J. Sekhri
  • Chairman of the Board
  • --
  • Dr. Kinneret Livnat Savitzky, PhD
  • Independent Director
  • --
  • Eran Perry
  • Independent Director
  • --
  • Sanford S. Zweifach
  • Independent Director
  • --
  • Gilead Halevy
  • Independent Director
  • --
  • Dr. Mathias Hukkelhoven, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg